{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:40:11Z","timestamp":1789540811092,"version":"build-2803163510"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":2242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s13311-017-0535-x","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:53:10Z","timestamp":1495716790000},"page":"614-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Emerging Treatments in Eating Disorders"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Lutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-017-0535-x_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.biopsych.2016.06.005","article-title":"Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice","volume":"81","author":"Xu P","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.appet.2017.01.005","article-title":"Impulsivity and test meal intake among women with bulimia nervosa","volume":"112","author":"Sysko","year":"2017","journal-title":"Appetite"},{"key":"10.1007\/s13311-017-0535-x_bib3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fpsyg.2016.01499","article-title":"Dietary restraint partially mediates the relationship between impulsivity and binge eating only in lean individuals: the importance of accounting for body mass in studies of restraint","volume":"7","author":"Coffino","year":"2016","journal-title":"Front Psychol"},{"key":"10.1007\/s13311-017-0535-x_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/eat.22606","article-title":"Impulsivity-related traits distinguish women with co-occurring bulimia nervosa in a psychiatric sample","volume":"49","author":"Reas","year":"2016","journal-title":"Int J Eat Disord"},{"key":"10.1007\/s13311-017-0535-x_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000352016","article-title":"Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control","volume":"68","author":"Merlotti","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1007\/s13311-017-0535-x_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cpr.2017.03.002","article-title":"Attention deficit hyperactivity disorder (ADHD) and disordered eating behaviour: a systematic review and a framework for future research","volume":"53","author":"Kaisari","year":"2017","journal-title":"Clin Psychol Rev"},{"key":"10.1007\/s13311-017-0535-x_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/0269881117691672","article-title":"Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine","author":"Vickers","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-017-0535-x_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/YPG.0b013e328335125d","article-title":"Fluoxetine response in impulsive\u2013aggressive behavior and serotonin transporter polymorphism in personality disorder","volume":"20","author":"Silva","year":"2010","journal-title":"Psychiatr Genet"},{"key":"10.1007\/s13311-017-0535-x_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/eat.20639","article-title":"Restraint, hunger, and disinhibition following treatment for binge-eating disorder","volume":"42","author":"Downe","year":"2009","journal-title":"Int J Eat Disord"},{"key":"10.1007\/s13311-017-0535-x_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/erv.2418","article-title":"Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder","volume":"24","author":"McElroy","year":"2016","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13803390903264122","article-title":"Preliminary evidence for a role for impulsivity in cognitive disinhibition in bulimia nervosa","volume":"32","author":"Kemps","year":"2010","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1007\/s13311-017-0535-x_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nrendo.2016.175","article-title":"The endocrine manifestations of anorexia nervosa: mechanisms and management","volume":"13","author":"Schorr","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1007\/s13311-017-0535-x_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.gastro.2004.10.043","article-title":"Gastrointestinal hormones and food intake","volume":"128","author":"Strader","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1007\/s13311-017-0535-x_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn.2139","article-title":"The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress","volume":"11","author":"Lutter","year":"2008","journal-title":"Nature Neurosci"},{"key":"10.1007\/s13311-017-0535-x_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.biopsych.2009.10.030","article-title":"Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner","volume":"67","author":"Perello","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3945\/ajcn.2008.27056","article-title":"Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders","volume":"89","author":"Prince","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1007\/s13311-017-0535-x_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pscychresns.2014.04.015","article-title":"Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa","volume":"223","author":"Holsen","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1007\/s13311-017-0535-x_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.psychres.2015.12.001","article-title":"Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa","volume":"235","author":"Monteleone","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1007\/s13311-017-0535-x_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","article-title":"Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study","volume":"56","author":"Hotta","year":"2009","journal-title":"Endocr J"},{"key":"10.1007\/s13311-017-0535-x_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12028","article-title":"One\u2010year intranasal application of growth hormone releasing peptide\u20102 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient","volume":"6","author":"Haruta","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1007\/s13311-017-0535-x_bib21","unstructured":"Motus Therapeutics, Inc.; Massachusetts General Hospital. Phase 2 pilot study to evaluate the safety and efficacy of RM-131 administered to females with anorexia nervosa. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01642550. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/ajp.147.7.882","article-title":"CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations","volume":"147","author":"Demitrack","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib23","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4088\/JCP.10m06617","article-title":"Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass","volume":"72","author":"Lawson","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib24","article-title":"Differential methylation of the oxytocin receptor gene in patients with anorexia nervosa: a pilot study","volume":"9","author":"Kim","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0535-x_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/erv.2354","article-title":"Association between the oxytocin receptor gene polymorphism (rs53576) and bulimia nervosa","volume":"23","author":"Kim","year":"2015","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.psychres.2015.05.040","article-title":"Severity of eating disorder symptoms related to oxytocin receptor polymorphisms in anorexia nervosa","volume":"228","author":"Acevedo","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1007\/s13311-017-0535-x_bib27","article-title":"The impact of oxytocin on food intake and emotion recognition in patients with eating disorders: a double blind single dose within-subject cross-over design","volume":"10","author":"Kim","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0535-x_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.psyneuen.2014.02.019","article-title":"Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa","volume":"44","author":"Kim","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1007\/s13311-017-0535-x_bib29","article-title":"The impact of intranasal oxytocin on attention to social emotional stimuli in patients with anorexia nervosa: a double blind within-subject cross-over experiment","volume":"9","author":"Kim","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0535-x_bib30","unstructured":"Fondation Lenval. Oxytocin and incitement to use olfactory stimuli in restrictive anorexia nervosa. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02333500. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v68n0621","article-title":"Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa","volume":"68","author":"Miller","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pscychresns.2004.09.003","article-title":"Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa","volume":"132","author":"Miller","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1007\/s13311-017-0535-x_bib33","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1210\/jc.2004-1181","article-title":"Testosterone administration in women with anorexia nervosa","volume":"90","author":"Miller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s13311-017-0535-x_bib34","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/jc.2011-0380","article-title":"Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study","volume":"96","author":"Miller","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s13311-017-0535-x_bib35","series-title":"Hormonal factors in the treatment of anorexia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib36","first-page":"789","article-title":"Anodal transcranial direct current stimulation over the dorsolateral prefrontal cortex improves anorexia nervosa: a pilot study","volume":"32","author":"Khedr","year":"2014","journal-title":"Restor Neurol Neurosci"},{"key":"10.1007\/s13311-017-0535-x_bib37","doi-asserted-by":"crossref","unstructured":"Bambino Ges\u00f9 Children's Hospital. New treatment perspectives in eating disorders: the efficacy of non-invasive brain-directed treatment. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02382497. Accessed Jan 12, 2017.","DOI":"10.3389\/fnbeh.2018.00133"},{"key":"10.1007\/s13311-017-0535-x_bib38","unstructured":"University Hospital, Montpellier. Transcranial Direct Current Stimulation (tDCS) and Anorexia Nervosa (STAR). Available at: http:\/\/clinicaltrials.gov\/show\/NCT02734108. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2011.06.002","article-title":"Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study","volume":"28","author":"Van den Eynde","year":"2013","journal-title":"Eur Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/erv.2266","article-title":"Improvements in symptoms following neuronavigated repetitive transcranial magnetic stimulation (rTMS) in severe and enduring anorexia nervosa: findings from two case studies","volume":"21","author":"McClelland","year":"2013","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nicl.2015.06.008","article-title":"Increases in frontostriatal connectivity are associated with response to dorsomedial repetitive transcranial magnetic stimulation in refractory binge\/purge behaviors","volume":"8","author":"Dunlop","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.1007\/s13311-017-0535-x_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/erv.2414","article-title":"Repetitive transcranial magnetic stimulation (rTMS) treatment in enduring anorexia nervosa: a case series","volume":"24","author":"McClelland","year":"2016","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148606","article-title":"A randomised controlled trial of neuronavigated repetitive transcranial magnetic stimulation (rTMS) in anorexia nervosa","volume":"11","author":"McClelland","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0535-x_bib44","unstructured":"University Hospital, Rouen. rTMS and body shape perception (STIMOREX). Available at: http:\/\/clinicaltrials.gov\/show\/NCT01717079. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib45","series-title":"High-frequency vs. low-frequency vs. sham DMPFC-rTMS for bulimia and anorexia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-244X-13-277","article-title":"Is deep brain stimulation a treatment option for anorexia nervosa?","volume":"13","author":"Oudijn","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib47","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1017\/S0033291714000981","article-title":"Deep brain stimulation for obsessive\u2013compulsive disorder: a systematic review and meta-analysis","volume":"44","author":"Kisely","year":"2014","journal-title":"Psychol Med"},{"key":"10.1007\/s13311-017-0535-x_bib48","doi-asserted-by":"crossref","first-page":"S29.e1-10","DOI":"10.1016\/j.wneu.2012.06.039","article-title":"Deep-brain stimulation for anorexia nervosa","volume":"80","author":"Wu","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1007\/s13311-017-0535-x_bib49","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.biopsych.2012.09.015","article-title":"Improvements in anorexia symptoms after deep brain stimulation for intractable obsessive-compulsive disorder","volume":"73","author":"McLaughlin","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib50","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(12)62188-6","article-title":"Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial","volume":"381","author":"Lipsman","year":"2013","journal-title":"Lancet"},{"key":"10.1007\/s13311-017-0535-x_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2215-0366(17)30076-7","article-title":"Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial","volume":"4","author":"Lipsman","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib52","series-title":"Oxford Health NHS foundation trust. Pilot study of deep brain stimulation for severe anorexia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib53","unstructured":"Beijing Tiantan Hospital; Beijing Pins Medical Co., Ltd. PINS stimulator system to treat severe anorexia nervosa. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02263404. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib54","unstructured":"Tang-Du Hospital. Deep brain stimulation of nucleus accumbens to treat severe anorexia nervosa. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02593695. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib55","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1172\/JCI71400","article-title":"Eating disorder predisposition is associated with ESRRA and HDAC4 mutations","volume":"123","author":"Cui","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-017-0535-x_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.celrep.2015.03.032","article-title":"Behavioral disturbances in estrogen-related receptor alpha-null mice","volume":"11","author":"Cui","year":"2015","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-017-0535-x_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biopsych.2016.09.024","article-title":"The eating-disorder associated HDAC4A778T mutation alters feeding behaviors in female mice","volume":"81","author":"Lutter","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2007-11108","article-title":"Rosiglitazone induces mitochondrial biogenesis in mouse brain","volume":"11","author":"Strum","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-017-0535-x_bib59","first-page":"49","article-title":"PPAR-\u03b3 agonists for the treatment of major depression: a review","volume":"50","author":"Colle","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/mp.2013.91","article-title":"Evidence for the role of EPHX2 gene variants in anorexia nervosa","volume":"19","author":"Scott-Van Zeeland","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2015.26","article-title":"Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa","volume":"21","author":"Shih","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2017.02.002","article-title":"Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa","author":"Shih","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1007\/s13311-017-0535-x_bib63","series-title":"Cannabinoid receptor (CB1) agonist treatment in severe chronic anorexia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib64","unstructured":"Cannabics Pharmaceuticals Inc. Cannabics capsules as treatment to improve cancer related CACS in advanced cancer patients. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02359123. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib65","unstructured":"BioGaia AB; Pediatric Department Clinical Hospital Centre Sestre milosrdnice Gastroenterology, Hepatology and Nutrition Ward. The role of Lactobacillus reuteri in children and adolescents with anorexia nervosa. Available at: http:\/\/clinicaltrials.gov\/show\/NCT02004288. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib66","unstructured":"Nationwide Children's Hospital. Treatment of anxiety and anorexia nervosa in adolescents (TAANA). Available at: http:\/\/clinicaltrials.gov\/show\/NCT01933243. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/hmbci-2014-0010","article-title":"Neuroendocrine control of satiation","volume":"19","author":"Asarian","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1007\/s13311-017-0535-x_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0b013e32834eb77d","article-title":"Cholecystokinin","volume":"19","author":"Dockray","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1007\/s13311-017-0535-x_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1744-6163.2011.00304.x","article-title":"Regulating satiety in bulimia nervosa: the role of cholecystokinin","volume":"48","author":"Hannon-Engel","year":"2012","journal-title":"Perspect Psychiatr Care"},{"key":"10.1007\/s13311-017-0535-x_bib70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.physbeh.2013.08.014","article-title":"CCK response in bulimia nervosa and following remission","volume":"122","author":"Hannon-Engel","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1007\/s13311-017-0535-x_bib71","unstructured":"St. Luke's-Roosevelt Hospital Center; GlaxoSmithKline. Effect of a CCK-1R agonist on food intake in humans (GSK). Available at: http:\/\/clinicaltrials.gov\/show\/NCT00600743. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr Metab"},{"key":"10.1007\/s13311-017-0535-x_bib73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/obr.12465","article-title":"Harnessing glucagon\u2010like peptide\u20101 receptor agonists for the pharmacological treatment of overweight and obesity","volume":"18","author":"Burcelin","year":"2017","journal-title":"Obes Rev"},{"key":"10.1007\/s13311-017-0535-x_bib74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/eat.22264","article-title":"Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa","volume":"48","author":"Dossat","year":"2015","journal-title":"Int J Eat Disord"},{"key":"10.1007\/s13311-017-0535-x_bib75","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3945\/ajcn.111.014837","article-title":"Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal","volume":"94","author":"Naessen","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1007\/s13311-017-0535-x_bib76","series-title":"Influence of appetite related hormones in binge eating behaviour among the overweight and obese","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnut.2015.00023","article-title":"The L-cell in nutritional sensing and the regulation of appetite","volume":"2","author":"Spreckley","year":"2015","journal-title":"Front Nutr"},{"key":"10.1007\/s13311-017-0535-x_bib78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2004.02176.x","article-title":"Altered ghrelin and peptide YY responses to meals in bulimia nervosa","volume":"62","author":"Kojima","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1007\/s13311-017-0535-x_bib79","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.biopsych.2005.01.004","article-title":"Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa","volume":"57","author":"Monteleone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib80","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000368160","article-title":"Different effects of cholestyramine on postprandial secretions of cholecystokinin and peptide YY in women with bulimia nervosa","volume":"70","author":"Rigamonti","year":"2014","journal-title":"Neuropsychobiology"},{"key":"10.1007\/s13311-017-0535-x_bib81","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.physbeh.2008.04.013","article-title":"Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED)","volume":"94","author":"Geliebter","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1007\/s13311-017-0535-x_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1059-1311(96)80036-7","article-title":"Topiramate: a new antiepileptic drug for refractory epilepsy","volume":"5","author":"Walker","year":"1996","journal-title":"Seizure"},{"key":"10.1007\/s13311-017-0535-x_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2016.02.002","article-title":"Topiramate monotherapy for weight reduction in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"114","author":"Paravattil","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1007\/s13311-017-0535-x_bib84","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1345\/aph.1R501","article-title":"Phentermine\/topiramate for the treatment of obesity","volume":"47","author":"Smith","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1007\/s13311-017-0535-x_bib85","article-title":"Successful treatment of binge eating disorder with combination phentermine\/topiramate extended release","volume":"17","author":"Guerdjikova","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1007\/s13311-017-0535-x_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-642-24716-3_20","article-title":"Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide","volume":"209","author":"Antel","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1007\/s13311-017-0535-x_bib87","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4088\/JCP.v67n1209","article-title":"Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial","volume":"67","author":"McElroy","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib88","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/eat.22159","article-title":"Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study","volume":"46","author":"Guerdjikova","year":"2013","journal-title":"Int J of Eat Disord"},{"key":"10.1007\/s13311-017-0535-x_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0196-9781(80)90008-X","article-title":"Naltrexone reduces weight gain, alters \u201c\u03b2-endorphin\u201d, and reduces insulin output from pancreatic islets of genetically obese mice","volume":"1","author":"Recant","year":"1980","journal-title":"Peptides"},{"key":"10.1007\/s13311-017-0535-x_bib90","first-page":"347","article-title":"A controlled trial of naltrexone in obese humans","volume":"9","author":"Malcolm","year":"1984","journal-title":"Int J Obes"},{"key":"10.1007\/s13311-017-0535-x_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0361-9230(85)90115-7","article-title":"Naltrexone and human eating behavior: A dose-ranging inpatient trial in moderately obese men","volume":"14","author":"Maggio","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1007\/s13311-017-0535-x_bib92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/clpt.1985.197","article-title":"Effects of long\u2010term therapy with naltrexone on body weight in obesity","volume":"38","author":"Atkinson","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1007\/s13311-017-0535-x_bib93","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1517\/14656560902775750","article-title":"Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity","volume":"10","author":"Plodkowski","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1007\/s13311-017-0535-x_bib94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/11537710-000000000-00000","article-title":"Naltrexone\/bupropion: Contrave(R); naltrexone SR\/bupropion SR","volume":"10","year":"2010","journal-title":"Drugs R D"},{"key":"10.1007\/s13311-017-0535-x_bib95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11920-015-0573-1","article-title":"Psychopharmacologic treatment of eating disorders: emerging findings","volume":"17","author":"McElroy","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1007\/s13311-017-0535-x_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/JCP.0000000000000427","article-title":"Effectiveness of nalmefene in Binge Eating Disorder: a case report","volume":"36","author":"Marazziti","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1007\/s13311-017-0535-x_bib97","series-title":"Treatment of binge eating disorder in obesity: naltrexone\/bupropion combination versus placebo","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib98","unstructured":"Lightlake Sinclair Ltd. Clinical trial on binge eating disorder, treatment with naloxone spray (BED). Available at: http:\/\/clinicaltrials.gov\/show\/NCT01567670. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167606","article-title":"Single-session transcranial direct current stimulation temporarily improves symptoms, mood, and self-regulatory control in bulimia nervosa: a randomised controlled trial","volume":"12","author":"Kekic","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0535-x_bib100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/eat.22554","article-title":"Effects of transcranial direct current stimulation (tDCS) on binge eating disorder","volume":"49","author":"Burgess","year":"2016","journal-title":"Int J Eat Disord"},{"key":"10.1007\/s13311-017-0535-x_bib101","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145704004420","article-title":"Repetitive transcranial magnetic stimulation (rTMS) in the double-blind treatment of a depressed patient suffering from bulimia nervosa: a case report","volume":"7","author":"Hausmann","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-017-0535-x_bib102","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2009.11.023","article-title":"Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders","volume":"67","author":"Van den Eynde","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/erv.2413","article-title":"Repetitive transcranial magnetic stimulation changes cerebral oxygenation on the left dorsolateral prefrontal cortex in bulimia nervosa: a near-infrared spectroscopy pilot study","volume":"24","author":"Sutoh","year":"2016","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fpsyt.2012.00030","article-title":"Unanticipated rapid remission of refractory bulimia nervosa, during high-dose repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: a case report","volume":"3","author":"Downar","year":"2012","journal-title":"Front Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/erv.2475","article-title":"A lack of clinical effect of high-frequency rTMS to dorsolateral prefrontal cortex on bulimic symptoms: a randomised, double-blind trial","volume":"24","author":"Gay","year":"2016","journal-title":"Eur Eat Disord Rev"},{"key":"10.1007\/s13311-017-0535-x_bib106","series-title":"High-frequency vs. low-frequency vs. sham DMPFC-rTMS for bulimia and anorexia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib107","series-title":"Transcranial magnetic stimulation and bulimic craving","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib108","series-title":"The effects of repetitive transcranial magnetic stimulation in obese people with BED","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib109","unstructured":"Bambino Ges\u00f9 Children's Hospital. New treatment perspectives in eating disorders: the efficacy of non-invasive brain-directed treatment. Available at: https:\/\/clinicaltrials.gov\/show\/NCT02382497. Accessed Mar 9, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.appet.2003.08.010","article-title":"Binge-type eating induced by limited access in rats does not require energy restriction on the previous day","volume":"42","author":"Corwin","year":"2004","journal-title":"Appetite"},{"key":"10.1007\/s13311-017-0535-x_bib111","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/oby.2010.46","article-title":"A model of binge-like eating behavior in mice that does not require food deprivation or stress","volume":"18","author":"Sahr","year":"2010","journal-title":"Obesity"},{"key":"10.1007\/s13311-017-0535-x_bib112","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1523\/JNEUROSCI.3237-12.2013","article-title":"Amelioration of binge eating by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation","volume":"33","author":"Tekriwal","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-017-0535-x_bib113","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1038\/tp.2015.197","article-title":"Nucleus accumbens deep brain stimulation in a rat model of binge eating","volume":"5","author":"Khokhar","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-017-0535-x_bib114","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/jpet.115.228221","article-title":"A novel nociceptin receptor antagonist LY2940094 inhibits excessive feeding behavior in rodents: a possible mechanism for the treatment of binge eating disorder","volume":"356","author":"Chen","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-017-0535-x_bib115","series-title":"Effectiveness of antibiotic treatment for reducing binge eating and improving digestive function in bulimia nervosa","year":"2017"},{"key":"10.1007\/s13311-017-0535-x_bib116","unstructured":"McLean Hospital. An open label trial of memantine in the treatment of bulimia nervosa and body dysmorphic disorder. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01038128. Accessed Jan 12, 2017."},{"key":"10.1007\/s13311-017-0535-x_bib117","series-title":"Effectiveness of baclofen in the treatment of people with bulimia nervosa or binge eating disorder","year":"2017"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-017-0535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:07Z","timestamp":1761807847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923014411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1878747923014411"],"URL":"https:\/\/doi.org\/10.1007\/s13311-017-0535-x","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Treatments in Eating Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-017-0535-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}